期刊文献+

几种临床常用药物对猪肝细胞色素P450酶系的影响 被引量:4

下载PDF
导出
摘要 研究了几种临床常用药物对猪肝微粒体细胞色素P450酶系的影响。红霉素、环丙沙星、地塞米松和乙醇,按5倍治疗剂量进行肌肉注射每天1次,连续给药10 d。差速离心法制备猪肝微粒体,B radford法测定蛋白浓度,分光光度法检测6种肝细胞色素P450酶含量及活性。结果表明,4种药物除环丙沙星外,均对P450酶的总活性产生显著影响(P<0.05),同时地塞米松组的微粒体蛋白含量和红霉素-N-脱甲基酶活性,乙醇组的苯胺-4-羟化酶活性和红霉素组的红霉素-N-脱甲基酶活性,与对照组相比均差异显著(P<0.05)。说明环丙沙星和红霉素对猪肝细胞色素P450酶系有选择性抑制作用,而地塞米松和乙醇对其起选择性诱导作用。
出处 《畜牧与兽医》 北大核心 2007年第2期36-38,共3页 Animal Husbandry & Veterinary Medicine
  • 相关文献

参考文献10

  • 1Estabrook R W.A passion for P450s (rememberances of the early history of research on cytochrome P450)[J].Drug Metab Dispos,2003,31(12):1461-1473.
  • 2吴伯镛.细胞色素P450酶与合理用药[J].药品评价,2005,2(4):301-302. 被引量:9
  • 3Zuber R,Anzenbacherova E,Anzenbacher P.Cytochromes P450 and experimental models of drug metabolism[J].J Cell Mol Med,2002,6(2):189-198.
  • 4江善祥,毛鑫智,J E Bayon,J Gonzalez-Gallego.实验感染肝片吸虫对水牛肝脏药物代谢酶的损伤作用[J].畜牧与兽医,2001,33(3):13-15. 被引量:3
  • 5徐叔云,卞廉如,陈修.药理实验方法学[M].3版.北京:人民卫生出版社,2001:781
  • 6Anzenbacher P,Anzerbacherova E,Zuber R,et al.Pig and minipig cytochromes P450[J].Drug Metab Dispos,2002,30 (1):100-102.
  • 7Lejus C,Fautrel A,Malledant Y,et al.Inhibition of cytochrome P450 2El by propofol in human and porcine liver microsomes[J].Biochem Pharmacol,2002,64(7):1151-1156.
  • 8Lu C,Li A P.Species comparison in P450 induction:effects of dexamethasone,omeprazole,and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man,Sprague-Dawley rat,minipig,and beagle dog[J].Chem Biol Interact,2001,134(3):271-281.
  • 9程婕,杨凌.细胞色素P450氧化还原酶的研究进展[J].中国药理学通报,2006,22(2):129-133. 被引量:26
  • 10Lowry J A,Kearns G L,Leeder J S,et al.Cisapride:A potential model substrate to assess cytochrome P4503A4 activity in vivo[J].Clin Pharmacol Ther,2003,73 (3):209-222.

二级参考文献28

  • 1袁浩龙.新型抗抑郁药与细胞色素 P450 系统[J].国外医学(精神病学分册),1997,24(1):39-43. 被引量:10
  • 2江绍基.临床肝胆疾病学[M].上海:上海科学技术出版社,1992.39.
  • 3Masimirembwa CM,Otter C,Berg M et al.,Heterologous expression and kinetic characterization of human cytochromes P450:validation of a pharmaceutical tool for drug metabolism research[J].Drug Metab Dispos,1999,27(10):1117-22.
  • 4Wang M,Roberts DL,Paschke R et al.Three-dimensional structure of NADPH-cytochrome P450 reductase:prototype for FMN- and FAD-containing enzymes[J].Proc Natl Acad Sci U S A,1997,94(16):p8411-6.
  • 5Shen AL et al.Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis[J].J Biol Chem,1989,264(13):7584-9.
  • 6Paine MJ et al.Role of the conserved phenylalanine 181 of NADPH-cytochrome P450 oxidoreductase in FMN binding and catalytic activity[J].Biochemistry,2001,40(45):p13439-47.
  • 7Shen AL,Kasper CB.Differential contributions of NADPH-cytochrome P450 oxidoreductase FAD binding site residues to flavin binding and catalysis[J].J Biol Chem,2000,275(52):41087-91.
  • 8Shen AL,Sem DS,Kasper CB.Mechanistic studies on the reductive half-reaction of NADPH-cytochrome P450 oxidoreductase[J].J Biol Chem,1999,274(9):5391-8.
  • 9Hubbard PA,Liang X,Schulz H,Kim J.NADPH-cytochrome P450 oxidoreductase.Structural basis for hydride and electron transfer[J].J Biol Chem,2001,276(31):29163-70.
  • 10Gutierrez A,Lian LY,Wolf CR et al.Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains[J].Biochemistry,2001,40(7):1964-75.

共引文献36

同被引文献74

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部